Marine Secondary Metabolite II, 2017
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 May 2017) | Viewed by 20993
Interests: isolation and stereostructural elucidation of new leads compounds in anti-inflammatory and anti-cancer drug discovery; exploration of the QQ and the QS system in bacteria symbiotic with sponges with the goal to create novel leads in antibacterial drug discovery; cyanobacteria as source of novel lead compounds and toxins
Special Issues, Collections and Topics in MDPI journals
This second edition of the Special Issue "Marine Secondary Metabolites" is aimed to collect papers on marine secondary metabolites produced by marine organisms and associated microorganisms, considered new scaffolds of potential lead compounds in drug research. Papers concerning neglected molecules, discovered within the frame of ongoing drug research programs, for which the bioactivity has not yet been explored, will be welcome with the idea to create a collection of novel molecules that specialists in antiproliferative, antikinases, antiinflammatory, antibacterial, quorum-quenching and quorum-sensing assays. This, in time, could translate into a number of novel lead compounds. Have a look in your lab and write about your "neglected molecule" which is as yet unknown to the scientific community! Reviews describing classes of secondary metabolites are also welcome.
Prof. Valeria Costantino
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Marine secondary metabolites
- Isolation, structural elucidation
- Stereochemistry assignments
- Mixed biogenesis metabolites